Anti-hepatitis Agents

Random Miscellaneous Quiz

Can you name the Anti-hepatitis Agents?

Quiz not verified by Sporcle

How to Play
Challenge
Share
Tweet
Embed
HintAnswer
P-kinetics: Oral bioavailability increased with high-fat meal, decreased with antacid.
PEG-IFN α-2a Class
P-kinetics: Clinical resistance is rare. Oral bioavailability decreased by food (taken w/ empty stomach). Renal elimination (serum concentration increased w/ altered kidney activit
SE: Dose-dependent hemolytic anemia. Depression, fatigue, irritability, nausea, insomnia.
Group MOA: Competively inhibit HBV DNA polymerase +/- incorporate into viral DNA causing chain termination. Phosphorylated to active forms intracellularly by cellular kinases.
P-kinetics:Oral bioavailability not affected by food. Emergence of resistance in long term use.
Use: The most potent anti-HBV agent. Adults only
MOA: A guanisine analog. Inhibits all 3 functions of HBV RNA-dependent DNA polymerase (base priming, reverse transcription of the -strand, synthesis of the + strand of HBV DNA.
MOA: A thymidine analog
Entecavir (Baraclude) Class
P-kinetics: Higher rate of complete response & less resistance vs. adefovir
SE: HA, fatigue, nausea. Potential mitochondrial toxicity (lactic acidosis & hepatic steatosis)
Adefovir dipivoxil (Hepsera) Class
Group MOA cont. (3) Protein kinase (activated by dsRNA): phosphorylates/inhibits eIF-2, therefore blocking PRO synthesis
P-kinetics: Synthetic (consensus). SC
MOA: A prodrug of adefovir (adenosine analogue). Slows suppression of HBV DNA; least seroconversion
Contraindications: Pts w/ uncorrected anemia, ESRD, preggo. Teratogenic: avoid pregnancy for > 6 mos thereafter
Group MOA: 3 major enzymes are activated by IFN-JNK/STAT signaling pathway: (1) 2',5' oligo A synthase: produces 2'5' oligo A.
P-kinetics: Oral (TID). P450 substrates (potential rx interactions)
MOA: A cytosine analogue
Lamivudine (3TC, Heptovir) Class
MOA: Serine protease inhibitors. Bind to inhibit HCV non-structural protein NS3
Use: Improve therapeutic response in pts (>18 yo) w/ HCV genotype 1 when combined w/ IFN/ribavirin
SE: Anemia, neutropenia, dysgeusia, skin rash (esp. telaprevir), increased QT intervals (telaprevir)
IFN alfacon-1 class
HintAnswer
Group MOA cont: Associated with mitochondrial DNA toxicity (by inhibiting DNA polymerase gamma)
SE: Nephrotoxicity (at high doses). Potential mitochondrial DNA toxicity
Use: HBV: Safer for pts w/ decompensated liver dz. For both adults & peds
P-kinetics: Prolonged intracellular half-life in HBV (than in HIV). Rapid oral absorption; eliminated unchanged. Used at lower doses for hepatitis than for AIDS.
Telbivudine (Tyzeka) Class
SE: Increased pancreatitis in HIV/HBV pts. Emergence of resistance (mutations of DNA polymerase)
P-kinetics: Natural. SC or IM
MOA: A prodrug (a guanosine nucleoside analogue). Phosphorylated by host cell enzymes; inhibits viral RNA-dependent polymerases.
Contraindications: Hepatic decompensation, autoimmune dz, cardiac arrhythmia, pregnancy
Group P-kinetics: Pills once a day for a year or longer
Drug MOA: PEG = polyethylene glycol
MOA: An adenosine analogue. Structurally similar to adefovir.
SE: Flu-like symptoms (fever, chills, myalgias, malaise). Neurotoxicity, myelosuppression, fatigue (chronic use). Transient hepatic enzyme elevation.
P-kinetics: Lipophilic (pivoxil) moiety enhances oral bioavailability.
Use: HBV treatment adults only
Tenofovir Class
Telaprevir Class
P-kinetics: Slower clearance (less frequent dosing). Dosage adjustment is needed in renal dysfunction
IFN α-2b Class
Use: Effective suppression of HBV DNA, normalization of ALT & reducing HBeAg. Adults only
Group MOA cont. (2) Ribonuclease L (activated by 2'5' oligo A): degrades mRNA.
Boceprevir Class
Use: Lamivudine-resistant HBV. Adults only
IFN α-2a/2b class
PEG-IFN α-2a/2b class

You're not logged in!

Compare scores with friends on all Sporcle quizzes.
Sign Up with Email
OR
Log In

You Might Also Like...

Show Comments

Extras


Your Account Isn't Verified!

In order to create a playlist on Sporcle, you need to verify the email address you used during registration. Go to your Sporcle Settings to finish the process.